Levi A. Garraway is an American oncologist. His research team was among the first to adapt genomics technologies to enable scalable, high-throughput clinical approaches to cancer gene mutation profiling. Head of Global Product Development and Chief Medical Officer (Member of the enlarged CEC since 2023).